BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 12, 2009
View Archived Issues
Alacizumab pegol and carboplatin/paclitaxel combination safe and active in advanced NSCLC
Read More
Shareholders of Schering-Plough approve proposed merger with Merck & Co.
Read More
MedImmune advances MEDI-573, MEDI-575 and MEDI-547 into phase I
Read More
Depomed reports results from phase I study of DM-1992 in Parkinson's disease
Read More
Cardiome and Astellas conduct confirmatory Kynapid trial under FDA SPA
Read More
Cephalon acquires Arana Therapeutics and its lead biologic ART-621
Read More
Biotec to proceed with phase III SBG trial following independent interim analysis
Read More
ALX-0081 shows superior preclinical antithrombotic activity compared to marketed antiplatelet drugs
Read More
Novel variegin-based class of thrombin inhibitors developed as anticoagulants
Read More
Endocyte discloses encouraging preliminary phase II data on EC-145 in advanced lung cancer
Read More
Novel small-molecule dimer disruptor inhibits herpesvirus protease activity in vitro
Read More
Selective P2Y12 receptor antagonist ASP-1645 displays potent preclinical antithrombotic activity
Read More
New series of selective cannabinoid CB2 receptor agonists described as analgesic candidates
Read More
Amgen discloses new CDK4 and CDK6 inhibitors for the treatment of cancer
Read More
Novartis discovers PI3K inhibitors for cancer treatment
Read More
Nicotinic receptor agonists in development at Pfizer for ADHD and other disorders
Read More
Abbott describes PAMs of neuronal nicotinic receptors for cognition disorders
Read More
Functional Genetics developing TSG101 inhibitors for viral infections
Read More
PI3K inhibitors presented by UCB for inflammatory and autoimmune diseases
Read More
Selective A2A receptor agonists claimed by PGxHealth for autoimmune conditions
Read More
Gene Signal presents phase I safety data for GS-101 eyedrops
Read More
Knopp Neurosciences to present phase II results of KNS-760704 in ALS
Read More
Label extension for Tracleer approved by the FDA
Read More
Array reports phase I results for ARRY-403 in type 2 diabetes
Read More
Topline results presented from phase III study of anti-influenza virus agent
Read More